← Open Payments lookup

MOBIN VARGHESE: Open Payments

NPI 1114504248 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,306 in 54 payments from 17 companies in 2025. Trend: 2023 $1,200 · 2024 $1,479 · 2025 $1,306

Food & beverage: $1,306
CompanyPaymentsAmount
Merck Sharp & Dohme LLC10$267
Amgen Inc.6$141
Novo Nordisk Inc6$137
Veloxis Pharmaceuticals, Inc.4$134
Takeda Pharmaceuticals U.S.A., Inc.4$102
Travere Therapeutics, Inc.4$98
Mallinckrodt Hospital Products Inc.4$78
Boehringer Ingelheim Pharmaceuticals, Inc.4$74
AstraZeneca Pharmaceuticals LP3$62
KYOWA KIRIN, INC.2$47

Products named: PREVYMIS, KRYSTEXXA, ENVARSUS, LIVTENCITY, JARDIANCE, ACTHAR, FARXIGA, Ozempic.

Industry payments across TX — which companies pay providers there.